Abstract. A monoclonal antibody raised against mitotic spindles isolated from CHO cells ([CHO1], Sellitto, C., and R. Kuriyama. 1988. J. Cell Biol. 106:431-439) identifies an epitope that resides on polypeptides of 95 and 105 kD and is localized in the spindles of diverse organisms. The antigen is distributed throughout the spindle at metaphase but becomes concentrated in a progressively narrower zone on either side of the spindle midplane as anaphase progresses. Microinjection of CHO1, either as an ascites fluid or as purified IgM, results in mitotic inhibition in a stage-specific and dose-dependent manner. Parallel control injections with nonimmune IgMs do not yield significant mitotic inhibition. Immunofluorescence analysis of injected cells reveals that those which complete mitosis display normal localization of CHO1, whereas arrested cells show no specific localization of the CHOI antigen within the spindle. Immunoelectron microscopic images of such arrested cells indicate aberrant microtubule organization. The CHO1 antigen in HeLa cell extracts copurifies with taxolstabilized microtubules. Neither of the polypeptides bearing the antigen is extracted from microtubules by ATP or GTP, but both are ,,060 % extracted with 0.5 M NaCI. Sucrose gradient analysis reveals that the antigens sediment at •llS. The CHO 1 antigen appears to be a novel mitotic MAP whose proper distribution within the spindle is required for mitosis. The properties of the antigen(s) suggest that the corresponding protein(s) are part of the mechanism that holds the antiparaUel microtubules of the two interdigitating half spindles together during anaphase.
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T HE mitotic spindle is the structure responsible for the equipartition of chromosomes during mitosis. Although there are numerous descriptions of the mitotic events visible at the microscopic level, we know little about the molecular aspects of spindle function. The inherent complexity of the spindle, combined with its extreme lability, has made such analyses difficult. Efforts to identify spindlespecific molecules from a variety of cell types have demonstrated the complexity of the spindle, but have thus far told us little about the molecules essential for mitosis. To go beyond descriptive biochemistry one needs a functional assay whereby to gauge the importance of a given molecule for mitotic progression.
There are at present two methods to determine the role of a given protein during mitosis. One powerful approach involves the creation of mutations that alter the gene(s) encoding a protein of interest. Although this method allows one to examine the function of a protein with precision, the requisite mutant cells must be found, and the list of mitosisblocking mutations is not very long at present (reviewed in Mclntosh and Koonce, 1989 ). An alternative approach in-volves the microinjection of antibodies against putative mitotic proteins into dividing cells. The microinjection method is advantageous because the antigen(s) recognized by the antibody need not be well characterized at the initiation of the experiments. Furthermore, the effects of the antibodies can be monitored in real time. Microinjection has been used successfully to probe the mitotic functions of MAP 4 (Izant et al., 1983) , calcium transport enzymes (Silver, 1986; Hafner and Petzelt, 1987) , a 62-kD phosphoprotein in mitotic sea urchin spindles (Dinsmore and Sloboda, 1989 ) and the mammalian homologue of yeast CDC 2 (Riawol et al., 1989) . In each case this method has provided useful information about the possible roles of the corresponding antigens during mitosis. In this paper we have used microinjection to probe the role in mitosis of an interesting but thus far poorly characterized antigen. Sellitto and Kuriyama (1988) described an mAb, CHO1, that was raised against spindles isolated from CHO ceils. The antigen recognized by this antibody appears to be a component of interphase nuclei and centrosomes as well as the mitotic matrix that binds to interzonal microtubules during anaphase. It is confined to the region where interdigitating microtubules overlap near the spindle midplane. To obtain evidence about the mitotic functions of the CHO1 antigen we have microinjected CHO1 ascites fluid or purified CliO1 IgM into PtKt cells at various times in mitosis. These injections led to mitotic arrest in a dose-dependent and stagespecific manner, suggesting that the CHO1 antigen is important for normal mitotic progression. Biochemical analyses have indicated that the polypeptides recognized by CHO1 bind to microtubules in vitro in a nucleotide insensitive, salt sensitive manner. Collectively, these data suggest that the CHO1 antigen(s) are novel mitotic microtubule-associated proteins (MAPs) t required for mitosis in PtK1 cells.
Materials and Methods

General Materials
Unless otherwise specified, all reagents were from Sigma Chemical Co. (St. Louis, MO). Taxol was the generous gift of Dr. Matthew Suffness (National Cancer Institute).
Preparation and Purification of Antibodies
An ascites fluid containing the CHO1 IgM (Sellitto and Kuriyama, 1988) was precipitated by the addition of 50% ammonium sulfate (pH 7.4), resuspended in half its original volume of PBS (136 mM NaCI, 80 mM Na2HPO, 3 mM KC1, 2 mM MgCI2, and 1 mM KPO4) dialysed against PBS or injection buffer (140 mM K +, 100 mM glutamic acid, 40 mM citric acid 1 mM MgC12, and 1 mM EGTA at pH Z4), and either purified further or concentrated, using a microconcentrator (Centricon 30; Amicon, Danvers, MA) to one-tenth the original volume. Further purification was performed by loading 0.5 ml of ammonium sulfate-precipitated antibody onto a 21-ml (1.5 x 27 cm) Sephacryl S-300 gel filtration column (Pharmacia Fine Chemicals, Piscataway, NJ) and eluting with PBS at room temperature (Jehanli and Hough, 1981) . 0.5-ml fractions were collected and analyzed electrophoretically followed by immunoblotting (Towbin et ai., 1979) with goat antibodies to the # chain of mouse IgM (Bio-Rad Laboratories, Richmond, VA) to locate the proteins of interest. Commercial mouse IgM (Calbiochem-Behring Corp., La Jolla, CA) was used on these blots as a standard. IgM-and non-IgM-containing fractions were pooled separately and concentrated with a Centricon 30 for subsequent mieroinjection. For some experiments the IgM was precipitated with 40% ammonium sulfate, chromatographed as before, then further purified by passage over a 700-/~1 protein G column (Pierce Chemical Co., Rockford, IL) that had been equilibrated with sodium phosphate buffer (145 mM NaCI, 7.5 mM NaH2PO4, and 2.5 mM NaI-IPO4 at pH 7.2). The flow through from this column which contained purified CHO1 IgM was coilected and concentrated to •10 mg/ ml as described above. In other experiments the ascites fluid from a mouse injected with a nonimmune, IgM-secreting hybridoma (gift of Bonnie Neighbors, University of Colorado) was processed and purified as above to serve as microinjection controls.
Microinjection
Antibody solutions were dialyzed against two changes of 300 vol of injection buffer (see above) then clarified by centrifugation for 30 rain in a microfuge, and stored at 4°C until used. In most cases, FITC-conjugated dextran was added to the antibody solutions at a concentration of 1 mg/ml before dialysis. Microinjections were performed according to Saxton and Mclntosh (t987) . Based on earlier calculations (Zavortink et al., 1983) we estimate injections to be ~10 % of the cell's volume. The protein concentrations of the injectates, as loaded into the needles, ranged from 1-50 mg/ml.
Cells to be microinjected were subcultured in Ham's F-12 medium supplemented with 10% FCS (Gibco Laboratories, Grand Island, NY) on etched glass coverslips (Bellco, Vineland, NJ). These coverslips facilitated subsequent identification of injected cells and their progeny. Coverslips containing ceils at '~70% confluence were tacked down to 35-mm petri dishes with valap (vaseline, lanolin, and paraffin at 1:1:1) then covered with medium. Selected mitotic cells were mieroinjected with glass micropipettes made on a Brown-Flaming P-77 pipette puller (Sutter Instruments, San Francisco, CA) from capillaries of 1.0 mm o.d. and containing an internal 1. Abbreviations used in this paper: MAP, microtubule-associated protein; PHEM, 60/~M Pipes, 25/~M Hepes, 10 mM EGTA, and 2 mM MgSO4; PMEG, 100 mM Pipes, 5 mM MgSO,,, 5 mM EGTA, 0.5 mM EDTA, 0.9 M glycerol, pH 6.9. filament to aid loading the needles (World Precision Instruments, New Haven, CT). Cells were injected at room temperature while being observed with a phase-contrast, water immersion objective (40x, n.a. 0.75; Carl Zeiss; Oberkochen, FRG). For most experiments between 30 and 40 cells per coverslip were injected over the course of 20 min.
After a series of injections, the coverslip was scanned and any injected cells that appeared to be injured were discounted from further analysis. Cells were placed in fresh medium in a 60-ram petri dish and placed in a 37"C incubator for 3 h. After this recovery period, injected cells were examined to determine their mitotic stage. Cells that had divided successfully were identified as pairs of fluorescent cells, whereas cells that had failed to divide were seen as individual fluorescent cells. These arrested cells were examined microscopically to determine the stage at which they had arrested. The microinjection experiments were performed under double-blind conditions. For each series of injections, two antibody solutions were prepared, a control IgM and CHO1 IgM. (The commercially prepared mouse IgM used as a control did not stain any mitotic structures in our immunofluorescent preparations.) Aliquots of these samples were then coded so that the individual performing the injections and subsequently scoring the cells did not know the identity of the samples.
Immunofluorescence Microscopy
Both PtKl and HeLa ceils were grown to ,~70% confluence on 12-ram circular coverslips as described above, then fixed directly in cold methanol, as described by Neighbors et ai. (1988) , or lysed for 1 min in PMEG buffer (100 mM Pipes, 5 mM MgSO4, 5 mM EGTA, 0.5 mM EDTA, and 0.9 M glycerol at pH 6.9) containing 1.0% Triton X-100 and 1 #M taxol, then fixed. CHO1 ascites or purified CHO1 IgM was typically used as a primary antibody at a 1:500 dilution in PBS for 2 h followed by three washes in PBS and a 1 h incubation with a Texas Red-conjugated goat anti-mouse secondary antibody (Fisher Scientific Co., Springfield, NJ) diluted 1:200 in PBS for 1 h. For double label experiments, cells labelled as described were washed for 40 rain in PBS, then incubated for 2 h with a mouse monoclonal antitubulin (Scholey et al., 1984) followed by an FITC-conjagated goat antimouse secondary antibody (U.S. Biochemical Corp., Cleveland, OH) diluted 1:100 in PBS for 1 h. Though this procedure used two primary antibodies from mouse, no cross-reactivity of the second goat antibody with the first primary antibody was observed. Control experiments in which the antitubulin incubation was omitted confirmed that the FITC-conjugated goat anti-mouse did not stain the CHO1/Texas Red-labeled cells. In some experiments DAPI (4',6-diarnidino-2-phenylindole dihydrochloride) was added to the final PBS wash (at 1 #g/ml) to stain the chromosomes. Cells injected with either CHO1 or control antibodies were processed as above, except that the first antibody incubation step was omitted. Coverslips were mounted in Gelvatol (Monsanto, Indian Orchard, MA) with 5% n-propyl gallate and observed on a Zeiss universal microscope equipped with both phase and epi-fluorescence optics, using a Zeiss phase contrast oil immersion lens (100×, n.a. 1.25). Images were recorded on T-Max 3200 film (Eastman Kodak Co., Rochester, NY) developed at 29°C according to the manufacturer's instructions.
Immunoelectron Microscopy
PtKl cells were grown as described above on glow discharged, Formvar and carbon-coated gold finder grids (Fullam, Latham, NY) . Mitotic cells were injected with CHO1 IgM as described, lysed for 1 rain at room temp with 0.2% Triton X-100 in PHEM buffer (60 mM Pipes, 25 mM Hepes, 10 mM EGTA, and 2 mM MgSO4) then fixed with 2.0% paraformaldebyde and 0.1% glutaraldehyde in PHEM for 20 rain at room temperature. Fixed cells were treated with 10 mg/ml sodium borohydride in 50% ethanol and 50% PBS then returned to PBS. Fixed cells were incubated with antitubulin for 2 h at 37°C followed by goat anti-mouse antibodies conjugated to 15 nm colloidal gold (Janssen Life Sciences, Olen, Belgium) for 3 h at room temperature. Labeled cells were dehydrated in a graded ethanol series, transferred to dry acetone, and then critical point dried from liquid CO2 in a CPD 020 (Balz rs, Hudson, NH). Dried specimens were viewed in a JEOL JEM-1000 electron microscope at 1 MeV.
Preparation of CH01 Antigen from HeLa Cells
HeLa cells were grown in suspension culture and harvested by centrifugation and separated into nuclear and cytoplasmic fractions according to the method of Arias and Dynan (1989) . Briefly, cells were lysed in a hypotonic buffer (10 mM Tris-HCl, pH 7.9, 10 mM KCI, 1.5 mM MgC12 and 1 mM DTT) and centrifuged at 3000 rpm in a rotor (model JS 13.1; Beckman InThe Journal of Cell Biology, Volume l 11, 1990
Figure/. Immunolocalization of the CHO1 antigen at different stages of mitosis in PtK, cells. Cells were lysed and prepared as described in Materials and Methods. The same cell for each stage is seen in phase contrast (a-g), after staining with anti-tubulin (a'-g') and CHO1 (a"-g"). Bar, 5 #m in all micrographs. struments, Palo Alto, CA) to separate nuclei and cytoplasm. Clarified cytoplasmic extracts were prepared by centrifugation in PMEG buffer, pH 6.9 containing soybean trypsin inhibitor, aprotinin, leupeptin, pepstatin, and benzamidine at 1/~g/rnl at 140000 g at 4*(2 for 45 rain. Nuclear fractions were prepared according to Arias and Dynan (1989) by extracting nuclei with 50 mM Tris-HC1, pH 7.5, 20% glycerol, 10% sucrose, 0.42 mM KCI, 5 mM MgCI2, 0.I mM EDTA, and 2 mM DTT for 30 rain at 4°C then centrifuging at 21,000 rpm in a rotor (model SW27; Beckman Instnunents) for 1.5 h at 4"C. Ammonium sulfate (33%) was then added to the supernatant from this spin. This mixture was stirred for 1 h at 4"C then centrifuged at 15,000 rpm in a rotor (model SW27; Beckman Instruments) for 15 rain at 4°C. The resulting pellet was resuspended in 50 mM Tris-HCl, pH 7.9, 1 mM EDTA, 20% glycerol, 12.5 mM MgC12, and 0.1 M KC1 containing the same cocktail of protease inhibitors used for the cytoplasmic extract. The resulting nuclear extract was then clarified in a microfuge. Clarified cytoplasmic and nuclear extracts were supplemented with 1 mM GTP and 10 ~M taxol, then incubated at 37"C for 5 rain, followed by the addition of 1 mg/ml taxol-stabilized microtubulcs (prepared from phosphocellulose purified tubulin [W'dliams and Detrich, 1979] ) and incubated at 37"C for an additional 40 rain. The micrombules and their associated proteins were pelleted through a 15% sucrose cushion for 1 h at 25,000 g at 30°C. The pellet of microtubules plus associated proteins (MTP) was washed in PMEG containing 10 t~M taxol, then extracted simultaneously with 5 mM MgATP and 5 mM MgGTP (in PMEG containing 10 t~M taxol) for 30 rain at 25"C. After extraction, the pellet and supernatant fractions were separated by centrifugation at 40,000 g for 30 rain at 30"C. This pellet was then resnspended in PMEG plus taxol and extracted sequentially with 0.5 M NaCl then 1.0 M NaC1 in PMEG containing 10 t~M taxol. To control for proteins that might sediment nonspecifically with microtubules, clarified cytoplasmic extracts were incubated and processed as above except both taxol and GTP were omitted and 0.1/~g/ml nocodazole was added to prevent the polymerization of micmtubules.
Sucrose Density Gradient Centrifugation
200-td samples of iligh speed supernatant prepared from HeLa cytoplasm were loaded onto 4.2 ml 5-20% sucrose gradients (pmimred in PMEG), then centrifuged at 300,000 g for &5 h at 4"C in an SW60 rotor (Beckman Instruments). For each run, two gradients were loa_~eM_ with I mg/ml of the following standards: cytochrome c (2.IS), catalase (ILLS), and tbyrnglobulin 09.283.
Each gradient was collected into 14 fractions of 300 ~1 each, adjusted to 1 mM GTP, 10 t~m taxol, and 1 mg/ml taxol-stabilized mierotubules. These fractions were incubated for 30 rain at room temperature, then centrifuged in an airfuge (Beckman Instruments) at 100,000 g for 15 rain at 22"C. Supernatants from these preparations were removed and the pellets were resuspended in one-third the original volume of PMEG before analysis via SDS-PAGE and immunoblotting.
Other Biochemical Procedures
Whole PtKI cell extracts were prepared by rinsing adherent cells with PMEG at 40C followed by removal of the cells by scraping with a rubber policeman. PtK1 cells were then rinsed twice in PMEG, re, suspended in 2 vol of PMEG containing the same cocktail of protease inhibitors used for HeLa cells, disrupted by sonication and boiled in gel sample buffer.
Protein conceatrations were measured according to the method of Bradford (1976) using bovine IgG as a standard. SDS-PAGE was performed on 7.5% acrylamide slab gels (0.75 mm thick) in a Mini Slab apparatus (Idea Scientific, Corvallis, OR) using a modification of the buffer system of Laemmli (1970) . The bis/acrylamide ratio was reduced to one-one hundredth to allow better transfer of proteins to nitrocellulose. Gels were stained with Coomassie blue and/or silver nitrate. For immunoblots, proteins were transferred to 0.22-1zm nitrocellulose (Schleicher & Schuell, Inc., Keene, NH) according to Towbin et at. (1979) for 1.75 h at 12 V in a Genie Mini Blot apparatus (Idea Scientific). Blots were probed sequentially with antibodies for 2 h each at 370C, then visualized via the immunopemxidase reaction (Bio-Rad Laboratories, Richmond, CA).
Results
Localization of CH01 in PtK Cells
The mAb designated CHO1 recognizes an epitope within the mitotic spindle and midbody of CHO ceils (Sellitto and Kuriyama, 1988 ). This cell type is not convenient for microinjection during mitosis because the cells are small, and they round up during prophase. PtKI cells, however, are larger and remain relatively flat during mitosis, making them suitable for microinjection. To determine the normal distribution of CHO1 in mitotic PtK~ cells, we processed these cells for double-label immunofluorescence, using CHO1 and an antitubulin mAb (Fig. 1) . Both lysed and unlysed cells displayed similar localization patterns, but the lysed preparations afforded a dearer immtmofluorescent signal, so we will focus our descriptions on them. In prophase cells, CHO1 stains fibers and punctate spots within the nucleus, but there is no detectable cytoplasmic staining (Fig. 1, a-a") . By prometaphase a dim, speckled staining by CHO1 is visible along the spindle microtubules (Fig. I, b-b") . This staining appears more uniform and intense by metaphase (Fig. 1, c-c") . At the onset of anaphase, CHO1 staining becomes localized to a discrete band of fibers that run between the separating chromosomes (Fig. 1, d-d") . By late anaphase, staining intensity increases and is more sharply localized to the region near the middle of the spindle where interpolar microtubules interdigitate (Fig. 1, e-e" ). During telophase, staining is seen only within the cytoplasmic bridge that separates the two daughter cells. At this stage CHO1 staining is brightest where inter'zonal micrombules remain interdigitated (Fig. 1,  f-f") . By the completion of cytokinesis staining is confined to the midbody (Fig. 1, g-g" ). From these images it appears that the CHO1 staining pattern is similar in both PtKI and CHO cells.
Microinjection of CHO1
We have examined the effect of microinjecting CHO1 into mitotic PtK~ cells. Ascites fluid containing either CHO1 or a nonimmune IgM at various concentrations ranging between 1 and 50 mg/ml was injected into PtK~ cells at different stages of mitosis (all concentrations cited refer to the total protein concentration of a given sample within the needle before~microinjection). Micminjection of mitotic cells with ~10% of their volume containing 12.5 mg/ml of CHO1 ascites fluid led to mitotic arrest in a stage-specific manner. When cells were injected during prophase, prometaphase or metaphase, 70-75% became arrested in a metaphase-like configuration (Table I ). Higher concentrations of ascites fluid proteins (up to 50 mg/ml) had no greater inhibitory Fractions 25-31 (+) and 39-45 (-) were pooled, concentrated, and denoted "IgM" and "non IgM," respectively.
affect, but at lower concentrations (<8 mg/ml) mitotic inhibition was proportionally less (Table I) . Significantly less inhibition was also observed when cells were injected after the onset of anaphase (20-30%). Injection of control ascites at 12.5 mg/ml resulted in 10-15 % inhibition, regardless of the time of injection. To control for the possibility that CHOl-injected cells were simply delayed in completing mitosis, we observed several injected cells 6-7 h after injection. None of the arrested cells divided. By that time they appeared to lose viability, as determined by their appearance in the phase contrast microscope and their permeability to trypan blue (data not shown).
To determine whether the mitotic inhibition observed in injected cells was really due to the action of CHO1 (as opposed to an unidentified component of the ascites fluid) we used gel filtration chromatography to enrich the preparation for IgM. SDS-PAGE and immunoblot analysis of the gel filtration column fractions with anti-mouse IgM antibodies revealed that these immunoglobulins eluted immediately after the void volume with few contaminating proteins (compared with commercially purified mouse IgM) (Fig. 2) .
To determine if the chromatography had damaged the ability of CHO1 to recognize its antigen, we tested the avidity of this partially purified IgM relative to the original ascites by serially diluting both preparations (at comparable protein concentrations) until no signal was detected via indirect immunofluorescence of fixed PtK1 cells. Assuming that the IgM constftuted approximately half of the ascites fluid proteins (see Fig. 2 ), we estimate that the chromatographed IgM was ~75 % as avid as its counterpart in the original ascites fluid.
Column fractions containing either the isolated IgM or non-IgM proteins were pooled separately, concentrated via ultrafiltration and dialysed as described in the Materials and Methods. Microinjection of purified IgM into mitotic cells resulted in a pattern of stage-specific mitotic arrest similar to that obtained with whole ascites, although the inhibition was significant at lower protein concentrations (compared with the whole ascites fluid) (Fig. 3) . Injection of CHO1 IgM at t>8 mg/ml into prophase, prometaphase or metaphase cells resulted in a metaphase-like arrest in 80-85 % of the cases. As with the ascites fluid, injections following anaphase onset had little effect. Control injections with a purified nonimmune IgM monoclonal antibody at equivalent concentrations led to 9-16 % arrest, regardless of the stage injected. The control cells that did not divide usually ceased mitotic progression in the stage at which they were injected, in contrast to the metaphase-like block observed with CHO1 injections.
To determine the response of PtKI cells to different doses of purified CHO1, we injected a dilution series of the antibody during prometaphase, then scored these cells for completion of mitosis 3 h later (Fig. 4) . Inhibition of mitotic progression decreased from 85 % at 8 mg/ml to 24 % inhibi- CHO1. Ceils were injected before the onset of anaphase with a dilution series of CHO1 IgM (1-15 mg/ml), with non IgM at 8 mg/ml (see Fig. 2 ) or with injection buffer alone. The number of cells injected with each sample is indicated (n=). tion at 1 mg/ml. For these experiments, two different control solutions were prepared. First we concentrated column fractions containing primarily non-IgM proteins to 8 mg/ml and injected this sample into PtK1 cells during prometaphase. Approximately 20-23 % of these cells became arrested at metaphase (Fig. 4) . These numbers are strikingly similar to those obtained with injection of 1 mg/ml of CHO1 IgM and probably reflect a contamination of the non-IgM column fractions with a small quantity of CHO1 IgM (see Fig. 2 ). To circumvent this contamination, we constructed a second control in which prometaphase cells were injected with commercially purified mouse IgM at 8 mg/ml. In these experiments only 8-10 % of the injected cells failed to complete mitosis (data not shown).
As a third control, we attempted to remove all contaminating IgG and further purify CHO1 IgM. CHO1 does not precipitate in low ionic strength buffers as described by Kiehart et al. (1986) . However, a second chromatographic step (as described in Materials and Methods) resulted in nearly homogeneous IgM which was devoid of IgG (Fig. 5 a) . This preparation and control BSA were injected into mitotic PtK~ cells before anaphase onset using a double blind experimental design (Fig. 5 b) . The degrees of mitotic arrest achieved with this material was similar to that seen with the singly chromatographed CHO1 IgM (compare Figs. 5 and 3). Based on these several controls we are confident that the metaphase-like arrest observed in cells injected with CHO1 is due to the action of the antibody.
To obtain a more detailed view of the effect of microinjected CHO1 on mitotic progression, injected cells were processed for indirect immunofluorescent staining to visualize either the injected antibody or the spindle and its chromosomes. Cells injected at prometaphase with 2 mg/ml CHO1 IgM (a concentration that did not normally inhibit mitosis) were fixed at various times after injection and reacted with secondary antibody conjugated to Texas Red to localize the bound CHO1 (Fig. 6, a and b) . In all cases the staining pattern of these injected cells was similar to that observed in uninjected cells stained directly with CHO1. Cells injected during anaphase with 8 mg/ml of CHO1 IgM (another treatment that normally has no effect on mitotic progression) also showed the normal localization of CHO1 (Fig. 6 c) . These results demonstrate that CHO1 injected into the cytoplasm can recognize its native antigen in a normal manner. Both spindle and chromosome morphology appeared normal in those ceils that were capable of dividing.
Next we focused on cells that were injected before anaphase onset with 8 mg/ml of CHO1 IgM and became arrested at metaphase. Cells injected before nuclear envelope breakdown proceeded to a metaphase-like state on schedule with control cells but did not develop further. The chromosomes in these arrested cells remained condensed near the spindle equator (Fig. 6, d and e). Staining these cells with antitubu- lin antibodies showed that their spindles look reasonably normal at the light microscopic level, although 30--40% of these cells contain one to three additional spindle poles (Fig.  6 e) . Visualization of CHO1 in the same cells revealed that the injected antibody was diffusely distributed throughout the cytoplasm with spindle staining barely detectable above background, in either lysed (Fig. 6 ) or unlysed preparations (data not shown). This observation is distinct from the spindle staining seen in fixed, uninjected metaphase cells treated directly with CHO1 (compare with Fig. 1, b" and c") . The dispersal of CHO1 antigen in cells arrested by CHO1 injection suggests that the mechanism of mitotic arrest may be related to the lack of proper localization of the CHO1 antigen in the spindle (see Discussion).
Spindle morphology in injected cells was studied at higher resolution by whole-mount immunoelectron microscopy, using antitubulin and colloidal gold-labeled secondary antibodies. Seven cells that were injected with 8 mg/ml CHO1 IgM at prometaphase and became arrested at metaphase were examined ultrastructurally. The overall morphology of these cells resembled similarly treated cells observed with phase microscopy, yet closer analysis of the microtubule structure of these cells revealed several features not detected in the immunofluorescent preparations. The cells examined appeared to have arrested before achieving a true metaphase configuration; often one or more chromosomes or chromosome fragments were several micrometers from the spindle equator (Fig. 7 a, arrow) . The microtubules in each half spindle were not organized into discrete spindle fibers, nor did they focus at the poles, as they do in uninjected cells at metaphase (Fig. 7 b) . Instead these microtubules emanate diffusely from the polar region. Organized centrosomes were not readily discernible in these cells. The ultrastructural data suggest that the microtubule organization of injected cells compromised, particularly near the poles.
Biochemical Characteristics of the CHOI Antigen
The microinjection experiments suggest that the CHO1 antigen might be an important mitotic MAP. To investigate this
The Journal of Cell Biology, Volume 111, 1990 possibility further we initiated a biochemical analysis of the protein(s) recognized by CHO1. It has been shown that CHO1 binds to polypeptides of •95 and ,'~105 kD on immunoblots of isolated CHO spindles (Sellitto and Kuriyama, 1988) . These polypeptides appeared to be minor components of these preparations, because corresponding gel bands could not be identified in Coomassie-stained gels of these preparations. As an alternative approach to characterizing the CHO1 antigen, we used microtubule affinity methods on HeLa cell extracts. We separated HeLa cells into nuclear and cytoplasmic components (see Materials and Methods), prepared a high-speed supernatant (HSS) from the cytoplasmic fraction, and then prepared a crude microtubule plus MAPs (MTP) pellet by supplementing it with preformed, taxolstabilized microtubules, followed by centrifugation. HeLa cells were chosen for this analysis because large quantities of these cells were available to us and the immunofluorescent staining pattern of CHO, PtK~, and HeLa cells is indistinguishable (Fig. 8, a and Sellitto and Kuriyama, 1988) .
Blots of the HeLa fractions probed with purified CHO1 antibody revealed the presence of two polypeptides of molecular weights similar to those described for CHO cells (,,o100 and ~115 kD). Faint antibody staining on blots was detected in the HSS (Fig. 8 c, lane 2) . The MTP fraction was greatly enriched for these antigens (over HSS), indicating that the CHO1 antigens bind to microtubules in vitro (Fig. 8 c, lane  4) . When the HSS was incubated with 0.1 #g/ml nocodazole to prevent microtubule assembly, the CHO1 antigens did not pellet in a comparable centfifugation (see Materials and Methods, data not shown). To examine the microtubule binding characteristics of the cytoplasmic antigen we extracted the cytoplasmic taxol-stabilized MTP with 5 mM MgATP and 5 mM MgGTP (Fig. 8 , lanes 5 and 6) and then with two concentrations of NaC1 (Fig. 8, lanes 7 and 8) . Both polypeptides remained associated with the microtubules after extraction with nucleotides (Fig. 8, lanes 5 and 6) , but 0.5 M NaCl removed between one-half and two-thirds of both polypeptides from the microtubule pellet (Fig. 8, lanes 7and 8) . Subsequent extractions with 1.0 M NaCI did not extract any more of the antigen from the microtubule fraction (Fig. 8, lanes   9 and 10) . These results indicate that the polypeptides recognized by CHO1 bind to exogenous bovine brain microtubules in an ATP/GTP insensitive, but partially salt-sensitive manner. The identification on Coomassie-stained gels of the polypeptides responsible for the observed immunoreaction with CHO1 was hampered by the presence of numerous bands in the relevant region of the gel.
We also asked whether the nuclear staining by CHO1, observed in immunofluorescentpreparations, was due to the same antigen as that recognized by CHO1 in the cytoplasm. HeLa nuclei and nuclear proteins, prepared according to Arias and Dynan (1989) , were fractionated into nuclear HSS and MTP as above, then analyzed on immunoblots with CHO1 (Fig. 8, lanes 11 and 12) . The CHO1 antigen in interphase nuclei comprise a microtubule binding protein of about the same R/as at that seen in the cytoplasm. This observation corroborates the immunofluorescent images of interphase and prophase cells and further suggests that the nuclear form of CHO1 antigen retains its microtubule binding properties.
To control for the use of two different cell types in these experiments, PtK~ cells for microinjecfion and immunofluorescence and HeLa cells for the biochemical analysis, we probed an immunoblot of whole PtKI cells with CHO1 IgM. This experiment revealed the presence of an immunoreactive band of,M00 kD and the absence of any other cross reacting polypeptides in PtK~ cells (Fig. 8, lane 13) .
The sedimentation velocity of the CHO1 cytoplasmic antigen from HeLa cells was determined for comparison with those of other known MAPs (reviewed in Olmstead, 1986) .
HeLa cell cytoplasmic HSS was fractionated on a 5-20 % sucrose gradient. Each fraction from the gradient was supplemented with preformed microtubules, centrifuged, and the resulting pellets were analyzed electrophorefically. Immunoblots of these fractions reveal that the CHO1 antigen(s) in HeLa cells sediment at l lS (data not shown).
Discussion
We have demonstrated that the epitope recognized by CHO1 is associated with the spindle microtubules of PtKI cells in stage-specific patterns that resemble those observed previously in CHO cells (Sellitto and Kuriyama, 1988) . Microinjection of sufficient quantifies of CHO1 antibody into mitotic PtKz cells inhibits mitotic progression, supporting the idea that the CHO1 antigen is an essential mitotic protein. The exact mechanism whereby the antibody arrests mitosis is, however, unclear. Examination of injected and arrested cells reveals that CHO1 blocks mitotic progression just before full metaphase; one or two chromosomes are often some distance from the spindle equator, suggesting that chromosome congression was partially impaired. The spindle microtubules of injected cells were also disorganized, failing to bundle into discrete kinetochore fibers and to focus at the poles; rather they terminated some distance from the centrosome and formed broad poles and a "stubby" spindle.
A comparison of the morphology of cells injected with CHO1 IgM or control IgM suggests several interpretations of the effects of the antibody injections. First, the antibody might be cross-linking adjacent microtubules within the spindle (directly or indirectly), effectively inhibiting further microtubule movements. We think this possibility unlikely, considering that cells injected during prophase proceed through most of prometaphase. Second, injected CHO1 might block the binding of the antigens to the spindle or remove them from the spindle during prometaphase and metaphase. Removal of these antigens from the spindle before anaphase onset may prevent the establishment of a normal metaphase configuration, causing the cells to arrest prior to this stage. Injection of CHO1 appears to delocalize the antigen from the spindle, resulting in a higher concentration of antigen within the cytoplasm (Fig. 6, d and e). Because the CHO1 antigen is localized in normal cells where it may serve to connect antiparallel spindle microtubules, the inactivation of the antigen by antibody injection might destabilize the spindle microtubules. Also, the formation of a stable interzone, which normally occurs during anaphase, might be impaired in the injected cells.
Considering the staining pattern of CHO1 in cells fixed during anaphase, we were surprised that injection of CHO1 had little effect on mitotic progression once anaphase commenced. From this we infer that once the CHO1 antigen has reached its target within the interzone during anaphase, it is protected from the perturbing effects of the antibody. This protection could arise if the association of CHO1 antigen with the interzonal microtubules and/or spindle matrix alters the antigen in such a way to make it less susceptible to removal by the antibody. The lack of an anaphase effect might also reflect either steric hindrance of the antibody by the closely aligned microtubules within the interzone or an insufficient amount of time for the antibody to have an effect before the CHO1 antigen accomplishes its task. Further, it is possible that the CHO1 antigen may have already served its mitotic function by the onset of anaphase.
An alternative mechanism whereby CHO1 might inhibit mitotic progression is suggested by the observation that cells arrested by antibody injection persist in a metaphase-like state for 6-7 h until they lose viability. This persistence is not observed in cells blocked with various microtubule poisons. Such drugged cells usually resume an interphase configuration within 2-3 h of treatment (Zieve et al., 1980) . That CHO1 arrested cells remain in mitosis for extended periods may mean that the corresponding antigens play a role in cell cycle regulation. The localization of the CHO1 antigen is similar in some ways to the distribution of a few molecules known to be important for mitotic control, such as the antigens recognized by MPM-2 (Vandre et al., 1984) and the inner centromere (INCENP) antigens (Cooke et al., 1987) .
We have been puzzled by the high concentration of CHO1 antibody required to inhibit mitotic progression. There are several possible explanations for the need of such a large quantity of antibody. First, there could be a large pool of CHO1 antigen in the cytoplasm. This is unlikely given the low levels of background staining observed with CHO1 even in unlysed preparations. Second, the avidity of the antibody might be low. Again this does not appear to be the case since CHO1 staining is detected on fixed cells at 1:5,000 dilution of the ascites fluid. Third, the CHO1 antigen might comprise an enzyme. Accordingly, it might be necessary to inactivate all of the antigen to block mitosis. Fourth, the PtK~ cytoplasm might be degrading the injected antibody. While we have no direct evidence on the half-life of the injected antibody, fluorescent IgGs injected into fibroblasts persist as diffuse fluorescence for several hours, suggesting that they remain soluble and probably retain their ability to bind antigen (Stacey and Allfrey, 1977) . Finally, the accessibility of the injected antibody to its antigen in the cytoplasm might be impaired. This is plausible given the extreme density of the cytoplasm near the spindle. Indeed, Fuchtbauer et al. (1985) have shown that even high concentrations of high-affinity antitubulin antibodies that cause disintegration of cytoplasmic microtubules do not affect spindle microtubules. Additionally, these authors observed the disintegration of cytoplasmic microtubules in lysed cell models at concentrations significantly lower than those required for similar effects in vivo. This observation supports the idea that cytoplasm is deleterious to the activity of some antibodies.
The CHO1 antigen appears to be a MAP. This assertion is based on the observation that the antigen binds to preformed, taxol-stabilized microtubules in vitro. Unlike many other previously described MAPs (Olmsted, 1986 ) the CHO1 antigen(s) does not bind to all cytoplasmic microtubules, rather it appears to colocalize only with interdigitating, antiparallel microtubules during mitosis. Given its localization, its molecular weight, its microtubule binding properties, and its sedimentation velocity, we suppose that the CHO1 antigen(s) make up a novel MAP. Several other proteins do, however, display similar immunolocalization patterns on interzonal microtubules during anaphase and telophase. Among these are epitopes identified using particular autoimmune sera, i.e., INCENPs (Cooke et al., 1987) ; a 38-kD antigen (Kingwell et al., 1987) ; a 200-kD antigen (Lyderson and Pettijohn, 1980) ; the tektins (Steffen and Linck, 1989) ; mitosis-specific phosphoproteins (Vandre et al., 1984) ; calpain II (Schollmeyer, 1988) ; a ll2-kD protein from grasshopper (Bastmeyer and Russell, 1987) ; a 205-kD thiophosphorylated protein in diatoms ; and a 225-kD phosphoprotein in sea urchin spindles (Kuriyama, 1989) . Additionally, Mullins and Mclntosh (1982) observed a ll5-kD doublet on Coomassie stained gels of isolated midbodies. CHO1 antigen(s) are, however, unique in the localization patterns they display through both interphase and mitosis.
The CHO1 antigen is distributed among a subset of spindle microtubules. During mitosis the CHO1 staining pattern changes markedly, shifting from diffuse spindle staining at metaphase to an increasingly narrow band of microtubules within the interzone during anaphase. The strong inference from the anaphase images is that the CHO1 antigen localizes specifically to regions where antiparallel microtubules from opposite poles interdigitate. If this is the case throughout mitosis, our data suggest that during prometaphase and metaphase some microtubules overlap almost all the way to the opposite pole. We were unable to test this assertion by immunoelectron microscopy because the CHO1 epitope is extremely sensitive to fixation with aldehydes. Several studies have, however, addressed this question. By reconstructing spindles from serial sections prepared for EM (McDonald, 1989) or by lysing cells with exogenous polarity markers (Euteneur et al., 1982; Haimo and Telzer, 1981; Heidemann and Mclntosh, 1980) , microtubules in prometaphase and metaphase ceils have been shown to extend far into the opposite half spindle. Although both these methods share several potential artifacts, the data suggest that before anaphase, some spindle microtubules extend very nearly to the pole opposite their site of initiation.
Our immunofluorescence observations show that CHO1 stains the nuclei of approximately one-fourth to one-third of interphase PtK1 cells. We have tested to see whether this staining was attributable to the same antigen as that seen in the spindle by using microtubule-affinity methods on nuclear extracts. Indeed, it appears that before nuclear envelope breakdown the CHO1 antigen is located in the nucleus. These observations suggest a scenario whereby CHO1 antigen is sequestered within the nucleus prior to mitosis (possibly to prevent its binding to cytoplasmic microtubules); then as the nuclear envelope disperses during the transition to prometaphase, CHO1 antigen is released into the cytoplasm to participate in the assembly and/or stabilization of the spindle.
Once mitosis is underway, it is clear that the CHO1 antigen moves relative to the surface of spindle microtubules. It might therefore be a component of a microtubule-dependent motor complex, perhaps involved in anaphase B . Unlike previously characterized microtubulebased motor molecules, however, the CHO1 antigen is not extracted from microtubules with MgATP or MgGTP. This property may result simply from the use of inappropriate buffer conditions or from an adventitious blocking of the relevant active sites on this antigen by interaction with another spindle component. In support of the latter idea, a previous report demonstrated that the CHO1 antigen is tightly associated with the spindle matrix, an amorphous, electron-dense material that begins to appear within the spindle during metaphase and that becomes concentrated in the interzone and midbody during anaphase and telophase (Sellitto and Kuriyama, 1988) . Extraction of isolated CHO midbodies with the detergent Sarkosyl revealed that the CHO1 staining persisted, even after most of the midbody microtubules had been solubilized. Thus, in addition to binding to spindle microtubules, it is likely that the CHO1 antigen interacts with other, as yet undefined spindle components. We plan to identify the other proteins that associate with the CHO1 antigen(s) in an effort to elucidate the role of these proteins in mitosis.
